Table 4.
Morality at 1 year after ICH onset
| All patients n (%) | Groups | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A (n = 84) | B (n = 114) | |||||||||
| Dead | Alive | P | Dead | Alive | Total | Dead | Alive | Total | P | |
| 86 (43.4) | 112 (56.6) | 31 (36.1) | 53 (63.9) | 84 | 55 (48.2) | 59 (51.8) | 114 | 0.112 | ||
| Age | 0.112 | |||||||||
| ≦60 | 50 (38.5) | 80 (61.5) | 0.052 | 11 (24.4) | 34 (75.6) | 45 | 39 (45.9) | 46 (51.4) | 85 | 0.017 |
| > 60 | 36 (52.9) | 32 (47.1) | 20 (51.3) | 19 (48.7) | 39 | 16 (55.2) | 19 (48.7) | 39 | 0.752 | |
| Gender | 0.112 | |||||||||
| Female | 22 (40.7) | 32 (59.3) | 0.640 | 9 (40.9) | 13 (59.1) | 22 | 13 (40.6) | 19 (59.4) | 32 | 0.983 |
| Male | 64 (44.4) | 80 (55.6) | 22 (35.5) | 40 (64.5) | 62 | 42 (51.2) | 40 (48.8) | 82 | 0.061 | |
| Diabetes | 0.112 | |||||||||
| No | 48 (37.8) | 79 (62.2) | 0.033 | 18 (30.0) | 42 (70.0) | 60 | 30 (44.8) | 37 (55.2) | 67 | 0.088 |
| Yes | 38 (53.5) | 33 (46.5) | 13 (54.2) | 11 (45.8) | 24 | 25 (53.2) | 22 (46.8) | 47 | 0.938 | |
| GCS | <0.001 | 0.147 | ||||||||
| 15-13 grade 1 | 3 (10.0) | 27 (90.0) | 0 (0.0) | 17 (100.0) | 17 | 3 (23.1) | 10 (76.9) | 13 | 0.070 | |
| 12-7 grade 2 | 29 (33.0) | 59 (67.0) | 0.017a | 8 (21.6) | 29 (78.4) | 37 | 21 (41.2) | 30 (58.8) | 51 | 0.055 |
| 6-3 grade 3 | 54 (67.5) | 26 (32.5) | <0.001b | 23 (76.7) | 7 (23.3) | 30 | 31 (62.0) | 19 (38.0) | 50 | 0.178 |
| NIHSS | <0.001 | 0.147 | ||||||||
| <15 grade 1 | 5 (15.6) | 27 (84.4) | 0 (0.0) | 17 (100.0) | 17 | 5 (33.3) | 10 (66.7) | 15 | 0.015 | |
| 15-20 grade 2 | 14 (28.0) | 36 (72.0) | 0.284a | 4 (18.2) | 18 (81.8) | 22 | 10 (35.7) | 18 (64.3) | 28 | 0.175 |
| >20 grade 3 | 67 (57.8) | 49 (42.2) | <0.001b | 27 (60.0) | 18 (40.0) | 45 | 40 (56.3) | 31 (43.7) | 71 | 0.698 |
| HV, mL | 0.112 | |||||||||
| ≦60 | 41 (31.3) | 90 (68.7) | <0.001 | 13 (21.3) | 48 (78.7) | 61 | 28 (40.0) | 42 (60.0) | 70 | 0.022 |
| > 60 | 45 (67.2) | 22 (32.8) | 18 (78.3) | 5 (21.7) | 23 | 27 (61.4) | 17 (38.6) | 44 | 0.165 | |
| IVH | <0.001 | 0.147 | ||||||||
| 0 | 16 (25.0) | 48 (75.0) | 0.918c | 3 (10.0) | 27 (90.0) | 30 | 13 (38.2) | 21 (61.8) | 34 | 0.010 |
| 1-4 | 16 (25.8) | 46 (74.2) | 5 (18.5) | 22 (81.5) | 27 | 11 (31.4) | 24 (68.6) | 35 | 0.253 | |
| 5-8 | 27 (75.0) | 9 (25.0) | <0.001a | 11 (73.3) | 4 (26.7) | 15 | 16 (76.2) | 5 (23.8) | 21 | 1.000 |
| 9-12 | 27 (75.0) | 9 (25.0) | 1.000b | 12 (100.0) | 0 (0.0) | 12 | 15 (62.5) | 9 (37.5) | 24 | 0.036 |
| Complications, n (%) | ||||||||||
| RB | 0.147 | |||||||||
| No | 79 (41.8) | 110 (58.2) | 0.042 | 30 (36.1) | 53 (63.9) | 83 | 49 (46.2) | 57 (53.8) | 106 | 0.164 |
| Yes | 7 (77.8) | 2 (22.2) | 1 (100.0) | 0 | 1 | 6 (75.0) | 2 (25.0) | 8 | 1.000 | |
| RF | 0.147 | |||||||||
| NO | 68 (38.4) | 109 (61.6) | <0.001 | 26 (32.9) | 53 (67.1) | 79 | 42 (42.9) | 56 (57.1) | 98 | 0.177 |
| Yes | 18 (85.7) | 3 (14.3) | 5 (100.0) | 0 | 5 | 13 (81.3) | 3 (18.8) | 16 | 0.549 | |
| PI | 0.147 | |||||||||
| No | 38 (32.8) | 78 (67.2) | <0.001 | 13 (26.0) | 37 (74.0) | 50 | 25 (37.9) | 41 (62.1) | 66 | 0.179 |
| Yes | 48 (58.5) | 34 (41.5) | 18 (52.9) | 16 (47.1) | 34 | 30 (62.5) | 18 (37.5) | 48 | 0.496 | |
| UGB | 0.147 | |||||||||
| No | 75 (41.0) | 108 (59.0) | 0.027 | 25 (32.5) | 52 (67.5) | 77 | 50 (47.2) | 56 (52.8) | 106 | 0.046 |
| Yes | 11 (73.3) | 4 (26.7) | 6 (85.7) | 1 (14.3) | 7 | 5 (62.5) | 3 (37.5) | 8 | 0.569 | |
P values were calculated using the Wilcoxon or Kruskal-Wallis rank sum tests. Groups: A, minimal invasive puncture and drainage; B, decompressive craniectomy; BP: blood pressure; SPB systolic blood pressure. DBP: diastolic blood pressure. GCS: Glasgow Coma Scale; NIHSS: National Institutes of Health Stroke Scale; HV: hematoma volume; IVH: intraventricular hemorrhage; RB: rebleed; PI: pulmonary infection; RF: renal failure; UGB: upper gastrointestinal bleeding; agrade 1 vs. grade 2; bgrade 2 vs. grade 3; cIVH 0 vs. IVH grade 1.